Reply to "The use of traditional Chinese medicines to treat SARS-CoV-2 may cause more harm than good"
- PMID: 32251725
- PMCID: PMC7128351
- DOI: 10.1016/j.phrs.2020.104775
Reply to "The use of traditional Chinese medicines to treat SARS-CoV-2 may cause more harm than good"
Conflict of interest statement
Declaration of Competing Interest There are no conflicts to declare.
Comment on
-
The use of Traditional Chinese Medicines to treat SARS-CoV-2 may cause more harm than good.Pharmacol Res. 2020 Jun;156:104776. doi: 10.1016/j.phrs.2020.104776. Epub 2020 Apr 3. Pharmacol Res. 2020. PMID: 32251726 Free PMC article. No abstract available.
References
-
- Dezhong Cheng, Wenju Wang, Yi Li. Analysis of 51 cases of new coronavirus pneumonia treated with traditional Chinese medicine Lianhua Qingwen granule: a multicenter retrospective study. Tianjin J. Trad. Chin. Med. 2020 http://kns.cnki.net/kcms/detail/12.1349.R.20200310.1024.004.html
-
- Xiaoxia Fu, Luping Lin, Xinghua Tan. Clinical study on treatment of 37 cases of new coronavirus pneumonia with integrated traditional Chinese and western medicine. Trad. Chin. Drug Res. Clin. Pharmacol. 2020 doi: 10.19378/j.issn.1003-9783.2020.00. - DOI
-
- Mingbo Yang, Shuangsuo Dang, Sheng Huang. Multi-center clinical observation of Reyanning mixture in the treatment of new coronavirus pneumonia. Chin. J. Exp. Trad. Med. Formulae. 2020 doi: 10.13422/j.cnki.syfjx.20201321. - DOI
-
- Zhao T., Tang H., Xie L. Scutellaria baicalensis Georgi. (Lamiaceae): a review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. J. Pharm. Pharmacol. 2019;71(9):1353–1369. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous